Statistics

Total Visits

Views
Tenofovir for the prophylaxis of HBV reactivation in anti-HBC-positive patients with hematologic malignancies treated with rituximab: Preliminary results of a randomized study (preblin study)16

Select a period of time:

Number of views in the range

Views
Tenofovir for the prophylaxis of HBV reactivation in anti-HBC-positive patients with hematologic malignancies treated with rituximab: Preliminary results of a randomized study (preblin study)7

Views

Views
May 20243
June 20242
July 20241
August 20240
September 20241
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
 

Top cities views

Views
Chicago2
Fort Worth1